List of SBIR/STTR awards granted to Glucosentient, Inc.

List of SBIR/STTR awards granted to Glucosentient, Inc.

List of SBIR/STTR awards granted to MARTINGALE RESEARCH CORPORATION

List of SBIR/STTR awards granted to Radiation Monitoring Devices, Inc.

List of SBIR/STTR awards granted to TIALINX, INC.

List of companies in CDTI's investment portfolio

List of companies founded by Saul Klein

where

SBIR/STTR Award Recipient

is

‌

Glucosentient, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ GlucoSentient, Inc SBIR Phase I Award, July 2018	A SBIR Phase I contract was awarded to Glucosentient, Inc. in July, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Glucosentient, Inc.		National Institutes of Health	SBIR	1R43HL142326-01A1	Phase I	225,000	July 1, 2018	sbir.gov/node/1568915
	‌ GlucoSentient, Inc SBIR Phase I Award, April 2021	A SBIR Phase I contract was awarded to Glucosentient, Inc. in April, 2021 for $224,018.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Glucosentient, Inc.		National Institutes of Health	SBIR	1R43AI162165-01	Phase I	224,018	April 1, 2021	sbir.gov/node/2187107
	‌ GlucoSentient, Inc SBIR Phase II Award,	A SBIR Phase II contract was awarded to Glucosentient, Inc. for $1,418,156.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Glucosentient, Inc.		National Institutes of Health	SBIR	272201800054C-0-0-0	Phase II	1,418,156		sbir.gov/node/1582323
	‌ GlucoSentient, Inc STTR Phase I Award, August 2016	A STTR Phase I contract was awarded to Glucosentient, Inc. in August, 2016 for $210,971.0 USD from the U.S. Department of Health & Human Services.	‌ Glucosentient, Inc.			STTR	1R41MH111337-01	Phase I	210,971	August 1, 2016	sbir.gov/node/1196471
	‌ GlucoSentient, Inc SBIR Phase I Award, April 2017	A SBIR Phase I contract was awarded to Glucosentient, Inc. in April, 2017 for $223,500.0 USD from the U.S. Department of Health & Human Services.	‌ Glucosentient, Inc.			SBIR	1R43HD092155-01	Phase I	223,500	April 1, 2017	sbir.gov/node/1247005
	‌ GlucoSentient, Inc SBIR Phase I Award, July 2012	A SBIR Phase I contract was awarded to Glucosentient, Inc. in July, 2012 for $149,999.0 USD from the National Science Foundation.	‌ Glucosentient, Inc.	National Science Foundation		SBIR	1215421	Phase I	149,999	July 1, 2012	sbir.gov/node/392222
	‌ GlucoSentient, Inc SBIR Phase II Award, October 2013	A SBIR Phase II contract was awarded to Glucosentient, Inc. in October, 2013 for $750,000.0 USD from the National Science Foundation.	‌ Glucosentient, Inc.	National Science Foundation		SBIR	1330934	Phase II	750,000	October 1, 2013	sbir.gov/node/683022
	‌ GlucoSentient, Inc SBIR Phase I Award,	A SBIR Phase I contract was awarded to Glucosentient, Inc. for $192,955.0 USD from the U.S. Department of Health & Human Services.	‌ Glucosentient, Inc.			SBIR	1R43DA035524-01	Phase I	192,955		sbir.gov/node/677696
	‌ GlucoSentient, Inc SBIR Phase I Award,	A SBIR Phase I contract was awarded to Glucosentient, Inc. for $136,794.0 USD from the U.S. Department of Health & Human Services.	‌ Glucosentient, Inc.			SBIR	1R43DK100213-01	Phase I	136,794		sbir.gov/node/677838
	‌ GLUCOSENTIENT INC SBIR Phase I Award, August 2023	A SBIR Phase I contract was awarded to Glucosentient, Inc. in August, 2023 for $269,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Glucosentient, Inc.		National Institutes of Health	SBIR	1R43DE033314-01	Phase I	269,000	August 17, 2023	sbir.gov/node/2511697

10 results

0 selected

10 results

0 selected